Kemena is the trade name of the drug icotinib hydrochloride. The clinical development of icotinib hydrochloride tablets has brought hope of life to the majority of cancer patients. This drug is a new type of anti-cancer drug and belongs to Western medicine. Everyone knows that Western medicine has many side effects, mainly reflected in adverse reactions in the gastrointestinal tract. So what is the effect of Kemena?
1. What is the efficacy?
Kemena is clinically used to treat cancer, with remarkable results and trustworthy results. The current survival rate has been greatly improved compared with previous years. This is not only due to the development and progress of medicine, but also the improvement of medical level. Targeted therapy with anti-cancer drugs is more accurate and has fewer side effects. Kemena is this type of small molecule targeted anti-cancer drug, which is a milestone in the history of anti-cancer drug development in my country. And it is precisely because of its remarkable efficacy and good reputation that it has brought many honors to Kemena.
As a new type of anti-cancer drug, the Kemena project has received support from the Ministry of Science and Technology’s Innovation Fund, the “863 Plan”, major new drug creation projects, and Zhejiang Province’s “Eleventh Five-Year Plan” major projects. It has also obtained Chinese patent registration. Through a large number of comparisons of similar drugs, it was found that Kemena has better anti-tumor efficacy than similar foreign products, and can be used clinically for the treatment of non-small cell lung cancer, pancreatic cancer, kidney cancer, etc. Treatment has brought hope to many patients.
Kemena is its trade name. Its scientific name is icotinib hydrochloride. Its main ingredient is icotinib hydrochloride. It is a Western prescription drug and a new domestic anti-cancer drug. Its The price is much cheaper than imported anti-cancer drugs, and it is very popular among patients.
We all know or have heard that the most commonly used method to treat cancer is chemotherapy. Although chemotherapy can kill a large number of cancer cells, it can also destroy the body's normal cells and reduce its own immune function. The side effects of chemotherapy are also very painful. It can be said that chemotherapy kills one thousand enemies and damages eight hundred. The new anti-cancer drug Kemena uses a targeted therapy method. In layman's terms, this drug specifically targets cancer cells and kills them like a missile targeting a target with precision. It does not damage healthy cells in the body.
2. Drug introduction
The main ingredient is icotinib hydrochloride.
Dosage form:
Tablets
Shape:
Kemena is a brown-red film-coated tablet, which appears similar after removing the coating. White.
Functional Indications:
Limited to second-line treatment of advanced non-small cell lung cancer.
Specifications/Chinese and Western medicines:
125mg, 21 tablets/box
Usage and dosage:
125mg/time, 3 times/day .
Adverse reactions:
The safety assessment of icotinib was based on study data from 312 patients with advanced NSCLC, including 224 patients who received a dose of 125 mg three times a day. Icotinib was generally well tolerated. The most common adverse reactions in the Phase III clinical trial (ICOGEN) are rash (39.5%), diarrhea (18.5%) and increased aminotransferase (8.0%). Most of them are grade I to II, generally seen 1-3 days after taking the drug. It is usually reversible and disappears on its own within weeks without special treatment. Table 1 lists adverse reactions reported in the ICOGEN trial with an incidence of ≥1%.
Contraindications:
Persons with a known severe allergic reaction to the active substance or any of the excipients of this product.